Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kory Kreimeyer"'
Autor:
Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, The Johns Hopkins Molecular Tumor Board Investigators, Jenna Canzoniero, Stuart A. Grossman, Kristen Marrone, Karisa C. Schreck, Valsamo Anagnostou, Christine Pratilas, Taxiarchis Botsis, Rena Xian, Chris Gocke, Tseh Ming-Lin, Eitan Halper-Stromberg, Ying Zou, Kent Hardart, Jonathan Spiker, Kory Kreimeyer, Ting He, Katie Fiallos, Dana Petry, Kala Visvanathan, Antonio Wolff, Cesar Santa-Maria, Raquel Nunez, Christian Meyer, John Laterra, Vered Stearns, Karen Smith, Deborah Armstrong, Rachel Karchin, Katerina Karaindrou, Lily Zandi, Marta Majcherska, Faith Too, Monique Makell, Jennifer Lehman, Timsy Wanchoo, Jaime Wehr, Michael Conroy, Selina Shiqing Teh.
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundDespite the putatively targetable genomic landscape of high-grade gliomas, the long-term survival benefit of genomically-tailored targeted therapies remains discouraging.MethodsUsing glioblastoma (GBM) as a representative example of high-gr
Externí odkaz:
https://doaj.org/article/5bcfd0838b504f0dae83f9e83188528c
Autor:
Kory Kreimeyer, Oanh Dang, Jonathan Spiker, Paula Gish, Jessica Weintraub, Eileen Wu, Robert Ball, Taxiarchis Botsis
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 2 (2022)
The US Food and Drug Administration (FDA) receives millions of postmarket adverse event reports for drug and therapeutic biologic products every year. One of the most salient issues with these submissions is report duplication, where an adverse event
Externí odkaz:
https://doaj.org/article/7eec6d5ca3354cf68344523790afa879
Publikováno v:
Studies in health technology and informatics. 295
Many decision support methods and systems in pharmacovigilance are built without explicitly addressing specific challenges that jeopardize their eventual success. We describe two sets of challenges and appropriate strategies to address them. The firs
Many decision support methods and systems in pharmacovigilance are built without explicitly addressing specific challenges that jeopardize their eventual success. We describe two sets of challenges and appropriate strategies to address them. The firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da936719991b17f260613af35d95757e
https://doi.org/10.3233/shti220749
https://doi.org/10.3233/shti220749
Autor:
Ting He, Anas Belouali, Jessica Patricoski, Harold Lehmann, Robert Ball, Valsamo Anagnostou, Kory Kreimeyer, Taxiarchis Botsis
Publikováno v:
Journal of Biomedical Informatics. 140:104335
Autor:
Suranjan De, Robert Ball, Paula Gish, Debra Boxwell, Vicky Chan, Taxiarchis Botsis, Kory Kreimeyer, Oanh Dang, Eileen Wu, Connie Cheng, Jarushka Naidoo, Gary L. Rosner, Allison Lardieri, Harold P Lehmann, Jonathan Spiker
Publikováno v:
Drug Safety. 43:905-915
The US FDA receives more than 2 million postmarket reports each year. Safety Evaluators (SEs) review these reports, as well as external information, to identify potential safety signals. With the increasing number of reports and the size of external
Autor:
Jessica, Patricoski, Kory, Kreimeyer, Archana, Balan, Kent, Hardart, Jessica, Tao, Valsamo, Anagnostou, Taxiarchis, Botsis
Publikováno v:
Studies in health technology and informatics. 289
Processing unstructured clinical texts is often necessary to support certain tasks in biomedicine, such as matching patients to clinical trials. Among other methods, domain-specific language models have been built to utilize free-text information. Th
Publikováno v:
Vaccine. 36:4325-4330
As part of a collaborative project between the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention for the development of a web-based natural language processing (NLP) workbench, we created a corpus of 1000 Vaccin
Autor:
Oanh Dang, Abhishek Pandey, Kory Kreimeyer, Matthew Foster, Taxiarchis Botsis, Wei Wang, Thomas Ly, Richard A. Forshee
Publikováno v:
Health Informatics Journal. 25:1232-1243
Structured Product Labels follow an XML-based document markup standard approved by the Health Level Seven organization and adopted by the US Food and Drug Administration as a mechanism for exchanging medical products information. Their current organi
Autor:
Oanh Dang, Robert Ball, Kory Kreimeyer, Gary L. Rosner, Jonathan Spiker, Taxiarchis Botsis, Monica A. Muñoz
Publikováno v:
Computers in Biology and Medicine. 135:104517
Background Our objective was to support the automated classification of Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) reports for their usefulness in assessing the possibility of a causal relationship between a drug produc